Trademark Overview
On Wednesday, April 30, 2025, a trademark application was filed for EUHEARING with the United States Patent and Trademark Office. The USPTO has given the EUHEARING trademark a serial number of 99163934. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 30, 2025. This trademark is owned by Shanghai Euhearing Therapeutics Co., Ltd.. The EUHEARING trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Liquid medicinal preparations for tinnitus treatment; Medicines for improvement of deafness gene; Medicinal preparations for treatment of deafness; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations for gene therapy for the treatment of deafness; medicinal preparations for improving hearing loss; Medicinal infusions for treating hearing loss
In-ear monitors for medical purposes; Ear trumpet; In-ear medicine delivery devices; Medical apparatus and instruments for use in surgery; Medical apparatus and instruments relating to nerve associated with the auditory pathway; Surgical and medical apparatus and instruments for use in otologic microsurgery; Surgical and medical apparatus and instruments for use in general surgery; Injection syringes (syringe barrels); Injection needles; Attachments for medical injection devices to aid in controlling the depth of the injections; Attachments for medical injection devices to aid in stabilizing flow during injection of pharmaceuticals; Syringes for injections; Injection instruments with needles; Injection device for pharmaceuticals
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing laboratory research services in the field of deafness gene expression; Development of gene-based medicines; Gene therapy research; Research in the field of gene editing technology; Scientific research in the nature of conducting clinical trials for others in the field of deafness treatment; Development of pharmaceuticals for cell and gene therapies; Laboratory research in the field of gene expression; Research and development services in the field of gene expression systems; Testing of pharmaceuticals for cell and gene therapies.
